Archive

Category Archives for "Press Releases"

Sichenzia Ross Friedman Ference LLP Advises Underwriter Aegis Capital on U.S. Initial Public Offering of Israeli Biopharmaceutical Company

biondvax pharmaceuticals

Represents first Israeli-American collaborative transaction between affiliated law firms SRFF LLP and DTKGC & Co.

New York, NY – May 15, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented the underwriter Aegis Capital Corp. on the U.S. initial public offering of BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV), continue reading >>

Sichenzia Ross Friedman Ference LLP Acted as Placement Agent Counsel on MabVax Therapeutic’s $11.7M PIPE

mabvax therapeutics

New York, NY – April 17, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that Axiom Capital Management Inc. has completed a private placement of MabVax Therapeutics Holdings, Inc. (OTC: MBVX) Units. MabVax is a clinical-stage biopharmaceutical company focused on developing vaccine and monoclonal anti-body based therapeutics. continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Citius Pharmaceuticals, LLC on $270,000 PIPE Financing

citius pharma

New York, NY — March 26, 2015 — Global Newswire — New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that the Firm represented Citius Pharmaceuticals, LLC (OTCQB: CTXR), a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets, in connection with a $270,000 PIPE transaction. continue reading >>

IBI Times Covers Partner Marc J. Ross’ Marijuana Business Law Class

New York, NY, March 24, 2015 – The International Business Times recently published an article discussing the marijuana business law course currently taught by Marc R. Ross, Esq., founding partner of Sichenzia Ross Friedman Ference LLP, at Hofstra University School of Law. The article, titled Amid Marijuana Legalization Efforts, US Law Schools Offer Pot Courses,” discusses a recent class which “focused on dissecting the tricky legal and policy issues related to legalized cannabis,” continue reading >>

Partner Marc J. Ross Speaks at Another Accredited Marijuana Symposium on the Financial Implications to Marijuana-Related Businesses & NY’s Compassionate Care Act

Hempstead, New York – March 12, 2015 – Global Newswire – Marc J. Ross, founding partner of Sichenzia Ross Friedman Ference LLP, was a featured presenter at Hofstra University School of Law’s symposium: “Puff the Magic Medicine – The Medical Marijuana Movement. The forum, which was both CLE and CME accredited, was part of the ongoing Garfunkel Wild Thought Leadership in Action Speaker Series, and examined the existing conflict between state and federal marijuana laws, continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Solar3D on $12.5M Public Offering of Units and Uplisting to the NASDAQ Capital Market

solar 3d

March 6, 2015 – New York, NY – (Global Newswire) – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Solar3D, Inc. (NASDAQ: SLTD), a provider of solar power solutions and the developer of a proprietary high efficiency solar cell, on a public offering of 3,000,000 units. continue reading >>

Contravir Pharmaceuticals, Inc. Announces Uplisting to NASDAQ Capital Market

contravir

Sichenzia Ross Friedman Ference LLP Advises ContraVir Pharmaceuticals on NASDAQ Uplisting

New York, NY – February 27, 2015 – (Global Newswire) – Nationally recognized securities andContra Contra
corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the discovery and development of antiviral therapies, in the Company’s uplisting to the NASDAQ Capital Market. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Sole-Book Running Manager in $3.0M Public Offering for CollabRX

collab rx

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. on $3.0 Million Public Offering of CollabRX, Inc.

New York, NY – February 26, 2015 — (GLOBE NEWSWIRE) — New York- based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented Aegis Capital Corp. as the sole book-running manager of a $3 million public offering for CollabRX, Inc. (NASDAQ: CLRX), a provider of cloud-based expert systems designed to inform healthcare decision-making. continue reading >>

Orbital Tracking Corp. Announces Share Exchange Agreement with Global Telesat & $1.1M PIPE

orbital tracking corp

Sichenzia Ross Friedman Ference LLP Advises Orbital Tracking Corp. in Share Exchange Agreement and $1.1 Million PIPE Financing

New York, NY – February 26, 2015 – (Global Newswire) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Orbital Tracking Corp. (OTCQB: TRKK), a global satellite services entity, in a share exchange agreement with Global Telesat Communications Limited, a privately held United Kingdom corporation (“GTCL”) and the shareholders of GTCL. continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. as Sole Book-Running Manager on $5.52M Public Offering of CollabRX, Inc.

collab rx

NY, New York – February 25, 2015 – Global Newswire—Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Aegis Capital Corp. as the sole book-running manager in a $5,520,000 public offering for CollabRX, Inc. (NASDAQ: CLRX),  a provider of cloud-based expert systems for selecting clinical treatments. continue reading >>

Partner Gregory Sichenzia Interviewed by TheStreet.com on Baidu’s Stock Growth Potential

February 23, 2015 – Financial news and services website TheStreet.com recently interviewed Sichenzia Ross Friedman Ference LLP Gregory Sichenzia on the stock growth potential for investors of Baidu, China’s largest search engine provider.

Baidu has long been touted as the “Chinese Google” and when asked to compare the two major companies, Mr. Sichenzia said:

“You can still buy Baidu relatively cheaply at a $76 billion market capital and that it is projected to experience 41 percent growth in 2015 while Google is quite expensive at $360 billion market cap with smaller growth potential for 2015,” said Gregory Sichenzia, a founding member of Sichenzia Ross Friedman Ference. “For this reason, Baidu is the better buy for stock investors, as Google, being a more mature company, is limited in upside for investors.”

Read the rest of the article here

Gregory Sichenzia, Esq.

Gregory Sichenzia, Esq.

Gregory Sichenzia, a founding member, counsels public and private companies in all securities laws matters, from complex financing transactions and listings on various stock exchanges through everyday regulatory requirements. He has also been responsible for structuring innovative merger and acquisition transactions. Throughout his career he has represented many companies and investment banks in initial public offerings of securities, and has represented numerous public companies in private equity financing transactions (“PIPEs”) and the resulting resale regist
Gregory Sichenzia, Esq.

Latest posts by Gregory Sichenzia, Esq. (see all)

    Sichenzia Ross Friedman Ference LLP Represents Laidlaw & Company (UK) Ltd. on a $20.0 Million Public Offering of Actinium Pharmaceuticals, Inc.

    actinium pharmaceuticals

    February 12, 2015 – New York, NY – (Global Newswire) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the sole book-running manager in an underwritten public offering for Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM), a biopharmaceutical company developing innovative targeted immunotheraputics for the treatment of advanced cancers. continue reading >>

    Sichenzia Ross Friedman Ference LLP Advises Trovagene Inc. on a $23.0M Public Offering

    trovagene

    New York, NY – February 11, 2015 – (Global Newswire) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, in an underwritten public offering of 5,111,110 shares of the company’s common stock. continue reading >>

    Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $28.7M Public Offering

    tonix pharmaceuticals

    New York, NY – February 10, 2015 – (Global Newswire) – New York-based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm represented Tonix Pharmaceuticals Holding Corp., a clinical-stage pharmaceutical company, in an underwritten public offering of 4,900,000 shares of common stock at a price of $5.85 per share. continue reading >>

    Partner Marc J. Ross Interviewed by International Business Times on Colorado’s Unique Marijuana Tax Problem

    February 10, 2015 – The International Business Times recently interviewed Marc J. Ross, founding partner of Sichenzia Ross Friedman Ference LLP, on the unique tax situation that Colorado now faces after earning more than $50 million in revenue from marijuana sales last year. Due to a 1992 constitutional amendment, the state has a limit on how much tax money the state can take in. continue reading >>

    Full Swing Golf Announces Endorsement Deal with Tiger Woods

    full swing golf

    Sichenzia Ross Friedman Ference LLP Represents Full Swing Golf, Inc. in an Endorsement Deal with Tiger Woods

    New York, NY – January 23, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) is pleased to announce that the Firm has represented San Diego-based golf simulator producer Full Swing Golf, Inc., a privately held company, in an endorsement agreement with golf icon Tiger Woods. continue reading >>

    Vuzix Corp. Announces $24.8M Investment from Intel

    vuzix

    Sichenzia Ross Friedman Ference LLP Represents Vuzix Corp. in $24.8M Investment From Intel

    NEW YORK, NY –( January 5, 2015) –New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm represented Vuzix® Corporation (OTCQB: VUZI) (“Vuzix” or the “Company”), a leading supplier of video eyewear and smart glasses products, in an investment transaction whereby Intel Corporation made a $24.8 million investment in Vuzix. Intel’s investment will be used for general working capital and will contribute to the acceleration of the introduction of Vuzix’s next generation wearable display products into the consumer market.

    Intel purchased 49,626 shares of Vuzix’s Series A Preferred Stock, convertible into 4,962,600 shares of the Company’s common stock at an initial conversion price of $5.00 per share. The shares issuable on conversion of the Series A Preferred Stock represent approximately 30% of Vuzix’s outstanding stock.

    The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Thomas A. Rose, Tara Guarneri Ferrara and Associate Jeffrey Cahlon.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a securities and corporate law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. The firm’s clients range from start-ups to established, listed companies; they include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. The firm also advises institutional investors on transactions involving complex securities law considerations and its practice includes the representation of clients located in the United States and throughout the world. To learn more about Sichenzia Ross Friedman Ference LLP, visit www.srff.com, SRFF’s LinkedIn and SRFF’s Twitter: @SRFFLLP.

     

    PlasmaTech Announces $14.0 M Public Offering and NASDAQ Listing

    plasmatech biopharmaceuticals

    New York, NY – December 24, 2014 – Press Release: New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm  represented H.C. Wainwright & Co. and Aegis Capital Corp. as underwriters in PlasmaTech Biopharmaceuticals, Inc.’s public offering of 3,500,000 shares of common stock and 3,500,000 warrants. The gross proceeds from the offering were $14,035,000 and the offering price was $4.00 per share and $.01 per warrant. The warrants have a per share exercise price of $5.00 and are exercisable immediately.  PlasmaTech common stock and warrants began trading on the NASDAQ Capital Market (effective December 19, 2014) under the symbols “PTBI” and “PTBIW” respectively.

    PlasmaTech Biopharmaceuticals, Inc. is a biopharmaceutical company focused on advanced targeted treatments for critical patient care. The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey J. Fessler and Marcelle Balcombe.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

     

    Great West Resources Inc. Announces Purchase of Globalstar Contracts

    great west resources

    Sichenzia Ross Friedman Ference LLP Advises Great West Resources, Inc. on Purchase of Globalstar Contracts from Global Telesat Corp. and Related License Agreement

    New York, NY – December 29, 2014 – (Global Newswire): New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has advised Great West Resources, Inc. (OTCQB: GWST) on the purchase of mobile, satellite and data network contracts from Global Telesat Corp. (“GTC”), a subsidiary of World Surveillance Group, Inc. The contracts permit Great West to utilize the Globalstar Inc. and Globalstar LLC mobile, satellite, voice and data network. GTC also granted to Great West a fully-paid and irrevocable non-exclusive license to use certain equipment owned by GTC or its affiliates consisting of “appliques” in connection with the Globalstar Contracts.  The purchased contracts and license agreement will allow Great West entry into the satellite voice and data sales and services industry.

    The Sichenzia Ross Friedman Ference LLP team was led by Partner Harvey Kesner and Associate Avital Even-Shoshan.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

     

    Medovex Corp. Announces $8.0 M IPO

    medovex corp

    Sichenzia Ross Friedman Ference LLP Represents Medovex Corp. in $ 8.0M Initial Public Offering

    New York, NY – December 29, 2014 – Global Medovex NasdaqNewswire – New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that the Firm has represented Medovex Corporation (NASDAQ: MDVXU), a producer of medical device products, in an initial public offering of 1,391,305 units. Each unit consisted of one share of common stock and one Series A Warrant at a price of $5.75 per unit. The IPO resulted in gross proceeds of $8,000,003 to the Company. The IPO was underwritten by Laidlaw & Company (UK) LTD.

    The units trade on the NASDAQ Capital Markets under the symbol “MDVXU” and the common stock and warrants will trade under the symbols “MDVX” and “MDVXW”, respectively on separation.

    Medovex is developing and commercializing the DenerVex® device, which is used in the treatment of conditions resulting from the degeneration of joints in the spine that cause back pain. In 2013, Medovex entered into a Co-Development Agreement with Dr. James Andrews, a renowned orthopedic surgeon who also is a director of the Company. Additionally Medovex intends to seek out acquisition opportunities through its world class Board of Directors which also includes Steve Gorlin, Major General C.A. “Lou” Hennies and Dr. Scott M. W. Haufe.

    The Sichenzia Ross Friedman Ference LLP team was led by Partners Harvey Kesner, Arthur S. Marcus and Associate Marc J. Adesso.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    SBI Investments Announces $6.5 Million Private Placement

    sbi investments

    Sichenzia Ross Friedman Ference LLP Represents SBI Investments in $6.5M Private Placement

    New York, NY (Global Newswire – Dec. 23, 2014) New York-based securities law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented SBI Investments LLC, a private investment firm whose primary focus is to provide creative and alternative funding solutions to global micro-, small- and mid-cap publicly-traded companies, in a private placement of LLC membership interests valued at $6,525,000.

    The Sichenzia Ross Friedman Ference LLP team was led by Partner Darrin Ocasio and Associate Marc Adesso.

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages

     

    Can-Fite Biopharma Ltd. Announces $8.0 M At-The-Market Registered Direct Offering

    can-fite biopharma

    Sichenzia Ross Friedman Ference LLP Advises Can-Fite Biopharma Ltd. On A $8.0 M At-The-Market Registered Direct Offering

    New York, NY – (Global Newswire) – 12/20/2014 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Israeli biopharmaceutical company, Can-Fite Biopharma Ltd. (TASE: CFBI; NYSE MKT: CANF) on an at-the-market registered direct offering of for gross proceeds of $8,000,000. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia, Associates Gary Emmanuel and Avital Even-Shoshan. H.C. Wainwright & Co., LLC acted as the Placement Agent in the offering.
    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    Synergy Pharmaceuticals Inc. Raises $200M Rule 144A Offering of 7.50% Convertible Senior Notes

    synergy pharmaceuticals

    Sichenzia Ross Friedman Ference LLP Represents Synergy Pharmaceuticals Inc. in $200M Rule 144A Offering of 7.50% Convertible Senior Notes

    New York, NY – (Global Newswire, November 5, 2014) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that it  represented Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical developer of drugs to treat gastrointestinal disorders and diseases, in a Rule 144A offering of $200 million of 7.50% Convertible Senior notes. The notes are convertibles into shares of Synergy Pharmaceutical’s common stock at a conversion price of approximately $3.11 per share.

    The SRFF team was led by Partner Jeffrey J. Fessler.

     

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference Advises MV Agusta on Partnership with Mercedes-AMG

    mv-augusta

    Sichenzia Ross Friedman Ference LLP Represents MV Agusta on Partnership with Mercedes-AMG

    New York, NY – (Global Newswire, November 3, 2014) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that it represented the U.S. subsidiary of MV Agusta, an Italian motorcycle manufacturer, on the negotiation of a cooperation agreement for a long-term partnership with sports-car and performance brand Mercedes-AMG of the Daimler AG. Pursuant to the partnership, which is subject to approval of the relevant European authorities, Mercedes-AMG will acquire a 25% interest in MV Agusta and Mercedes-AMG will appoint one member of MV Agusta’s board of directors. As a 100% subsidiary of Daimler AG, Mercedes-AMG GmbH is the sports-car and performance brand of Mercedes-Benz Cars. Through the sales and marketing partnership with Mercedes-AMG, MV Agusta expects to accelerate company growth and to widen its customer base worldwide.

    The Sichenzia Ross Friedman Ference LLP team was led by Associate Marc J. Adesso.

    Media Contact:

    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    ContraVir Pharmaceuticals Announces $9.0 Million Private Placement

    contravir

    Sichenzia Ross Friedman Ference LLP Advises ContraVir Pharmaceuticals on $9.0 Million Private Placement

    New York, October 28, 2014 (Global Newswire) – New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, on a $9 million private placement consisting of Series A Convertible Preferred stock to a non-U.S investor.

    Pursuant to the private placement, the Series A Preferred Stock can be converted into shares of common stock at the conversion price of $0.48 per share. The Sichenzia Ross Friedman Ference LLP team was led by partner Jeffrey J. Fessler.

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    CEL-SCI Corporation Announces $6.0 Million Public Offering

    cel sci

    Sichenzia Ross Friedman Ference LLP Represents CEL-SCI Corporation on $6.0 Million Public Offering

    New York, NY – October 29, 2014 – GLOBAL NEWSWIRE – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that it has advised Laidlaw & Co. (UK) Ltd. as the Lead Underwriter in a $6 million public Public Offering of CEL-SCI Corporation (NYSE MKT: CVM), a late-stage biotechnology company focused on oncology research and drug development. The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of common stock and warrants at a combined price of $0.76 per unit. Pursuant to the offering, CEL-SCI issued one warrant to purchase common stock for every four shares sold. The warrants have an exercise price of $1.25 per unit. The Sichenzia Ross Friedman Ference LLP team was led by Partner Richard A. Friedman and Associate Stephen Cohen.

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Towerstream Corporation Announces $35.0 Million Secured Financing

    towerstream

    New York, NY – October 27, 2014 – Global Newswire – New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented Towerstream Corporation in a five-year, $35 million secured debt financing agreement with affiliates of Melody Capital Partners, LP.

    As part of the financing, Towerstream issued warrants to purchase 3,600,000 shares of common stock of which two-thirds of the warrants will have an exercise price of $1.26 and one-third will have an exercise price of $0.01. The Sichenzia Ross Friedman Ference LLP team was led by partner Harvey J. Kesner, Counsel Ed Schauder and Associate Avital Even-Shoshan.

     

    Media Contact:
    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Single Touch on a $11.0 M Debt and Equity Financing Consisting of a $10.0 M Secured Financing and a $1.0 M PIPE with Fortress Investment Group

    sito - single touch interactive

    New York, NY – Oct 8, 2014 – GLOBAL NEWSWIRE – New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Single Touch Interactive, Inc. (OTC BB: SITO), a mobile media solutions provider, in a $11 million debt and equity financing where Single Touch secured a PIPE investment equaling $1 million in equity and $10 million in secured debt.

    As part of the investment, Single Touch will issue 2,619,539 shares of its common stock valued at $0.3817 per share. The Sichenzia RossFriedman Ference LLP  team was led by Partner Gregory Sichenzia, Marcelle Balcombe and Counsel Peter DiCharia.

    Media Contact:

    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Rightscorp, Inc. on a $2.65M PIPE Offering

    rightscorp

    NEW YORK, SEPT. 25, 2014 (GLOBE NEWSWIRE) — New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Rightscorp, Inc. (OTC QB: RIHT), a provider of monetization services for artists and holders of copyrighted intellectual property, on a $2.65 million private financing. The offering consisted of a sale of 10,608,000 shares of the company’s common stock and warrants to purchase 15,912,000 shares of common stock at $0.25 per Unit for a total offering of $2,652,000. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia and Of Counsel Henry Nisser.

    Media Contact

    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Citius Pharmaceuticals, LLC on a Reverse Merger and $2.04 Million Pipe Financing

    citius pharma

    September 18, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Citius Pharmaceuticals, LLC (OTCQB: CTXR) – a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets- in connection with a Share Exchange and Reorganization Agreement between Citius Pharmaceuticals, LLC, Citius Pharmaceuticals, Inc. (formerly known as Trail One. Inc.) and the beneficial holders of the membership interests of Citius.

    Pursuant to the “Exchange Agreement”, Citius Pharmaceuticals, Inc. issued common stock to the holders of the membership interests of Citius representing approximately 72.0% of the outstanding shares of common stock.

    In connection with the “Exchange Agreement”, Sichenzia Ross advised Citius on a private offering whereby Citius sold 3,4000,067 Units for a purchase price of $0.60 per Unit for a total value of $2.04 million. Each Unit sold consisted of one share of common stock and a five-year warrant. The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia and Arthur S. Marcus.

    Media Contact:

    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Labor Smart, Inc. on a $1.1 million Private Placement of Common Stock.

    laborsmart

    August 18, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Labor Smart, Inc. (OTCBB: LTNC), a provider of on-demand construction, manufacturing and retail staffing , in a $1.1 million private placement pursuant of Regulation D. The transaction consisted of original issue discount debentures convertible at $0.15 per share and 100,000 shares of common stock. The Sichenzia RossFriedman Ference LLP  team was led by Gregory Sichenzia and Jeff Cahlon.

     

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Acted as Lead Investor Counsel on VBI Vaccines’ $5.25 million private placement

    Securities Law Firm | Sichenzia Ross Friedman Ference LLP

    vbi vaccines

    NEW YORK, August 1, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announces that it represented the lead investor in a $5.25 million private placement conducted by VBI Vaccines Inc. (NASDAQ: VBIV), formerly Paulson Capital (Delaware) Corp. The offering, which originally closed into escrow on July 25, 2013, consisted of the sale of one unit of VBI’s securities, made up of shares of Common Stock, Series A Preferred Stock and two class of warrants exercisable into shares of VBI’s Series B Preferred Stock. The release of the funds and securities in escrow was subject to certain conditions precedent which was satisfied on July 25, 2014, at which time the funds and securities were released.

    VBI Vaccines, Inc. is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. The Sichenzia Ross Friedman Ference LLP team was led by partner Harvey Kesner and associate Tara Guarneri-Ferrara.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Intellect Neurosciences, Inc. on $1.2 Million PIPE offering

    intellect neurosciences

    Intellect_NeurosciencesNew York, July 31, 2014 (Global Newswire) – New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Intellect Neurosciences, Inc. (ILNS: OTC US) on a $1.2 million private placement consisting of Series F Preferred Stock and Warrants. Intellect Neurosciences Inc. is a biopharmaceutical company engaged in the discovery and development of disease modifying therapeutic agents for the treatment and prevention of Alzheimer’s disease. The Sichenzia Ross Friedman Ference LLP team was led by partner Arthur Marcus.

     

    Media Contact:
    pr@srfkllp.com
    (212)-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Tonix Pharmaceuticals on $7.8 Million Public Offering

    tonix pharmaceuticals

    NEW YORK, July 16, 2014 (GLOBE NEWSWIRE) –New York based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a clinical-stage pharmaceutical company focused on researching common disorders of the central nervous system, on a recently completed $7.8 million registered direct public offering pursuant to Tonix’s shelf registration statement. The offering consisted of 657,000 shares of common stock sold at $11.90 per share. Roth Capital Partners acted as the sole placement agent in this offering. The Sichenzia Ross Friedman Ference LLP team consisted of partners Marc J. Ross and James M. Turner and associate Sharon Carroll.

    Media Contact
    pr@srfkllp.com
    (212)-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company on $2.1 Million Private Placement for Nanox Imaging PLC

    nanox

    NEW YORK, July 2, 2014 (GLOBE NEWSWIRE) – New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented J.P. Turner & Company as the sole placement agent on a $2.1 Million private placement of the ordinary shares of Nanox Imaging PLC.

    Nanox Imaging PLC is a company incorporated and registered in Gibraltar that is developing a product to replace the current, century-old, “Hot Cathode” X-Ray technology with “Cold Cathode” technology. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia, Tom Rose and David Manno.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sicheniza Ross Friedman Ference Advises Cell Source Ltd. on Reverse Merger

    cell source

    NEW YORK, July 1, 2014 (GLOBE NEWSWIRE)
    New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Cell Source Limited (Israel) in a reverse merger transaction whereby Cell Source Inc., a Nevada based publicly traded company under the symbol “CLCS: OTCQB”, acquired 100% of the capital stock of Cell Source Limited, an Israeli biotechnology company engaged in developing cell therapy treatments.

    This past February, Sichenzia Ross represented Cell Source Limited in a private placement transaction consisting of 4.8 million units of securities raising approximately $3.6 million. Each unit consisted of one share of common stock and one common stock purchase warrant.

    The Sichenzia Ross Friedman Ference LLP team was led by partner Gregory Sichenzia, David Manno and associate Jay Yamamoto.

    Sichenzia Ross Media Contact:
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Represents MusclePharm Corporation In An Endorsement Deal with Tiger Woods

    musclepharm logo

    On June 18, 2014, SRFF’s client, MusclePharm Corporation (OTCBB: MSLP), announced an endorsement deal with legendary golfer Tiger Woods. Under the terms of the agreement, the MusclePharm logo will appear on Mr. Wood’s golf bag and Mr. Woods will serve as a brand ambassador for the company.

    Sichenzia Ross’s Sports and Entertainment Law Practice Group represented MusclePharm in connection with the preparation and negotiation of this endorsement agreement. The transaction was led by SRFF attorneys Ed Schauder, Harvey Kesner and Tim O’Brien.

    In addition to the MusclePharm transaction with Mr. Woods, in the past 12 months, the Sichenzia Ross Friedman Ference LLP Sports and Entertainment Law Practice Group has consummated numerous transactions that have involved well-known athletes and celebrities including Governor Arnold Schwarzenegger, Mariano Rivera, Carmelo Anthony, Patrick Ewing, Mike Tyson, the Joe DiMaggio Estate, Chris Paul, Don Larsen, the 1994 New York Rangers, Andy Pettitte and Joe Torre. The group has also recently advised Steiner Sports in connection with its sponsorship and partnership agreements with the New York Yankees, Madison Square Garden, the Brooklyn Nets, the Boston Red Sox and Syracuse University.

    For more information on MusclePharm, visit their website at www.musclepharm.com.

    For more information about Sichenzia Ross Friedman Ference LLP’s Sports & Entertainment Law Practice Group contact Ed Schauder at (212) 930-9700 or visit the Firm’s website at www.srff.com.

    Sichenzia Ross Friedman Ference LLP Advises NTS Inc. on $140.0 Million Acquisition Transaction

    nts incorporated

    NEW YORK, June, 6, 2014 (GLOBE NEWSWIRE) –New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has acted as counsel to NTS Inc. (NYSE MKT LLC: NTS) in a merger transaction valued at approximately $140.0 million where Tower Three Partners LLC, a leading operationally oriented private equity firm, acquired all the capital stock of NTS Inc. for $2.00 per share. NTS is a provider of high speed broadband services, including internet access, digital TV and other services to residential and business customers in northern Texas and southeastern Louisiana. The Sichenzia Ross Friedman Ference LLP team was led by partner Arthur Marcus and Of Counsel Henry Nisser. Mr. Marcus represented NTS, Inc. for more than seven years from its early days as a long distance provider in Israel to the present day, where it is an international telecommunications firm.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises FreeSeas Inc. on $25.0 Million Public Offering of Preferred Stock and Warrants

    freeseas

    NEW YORK, June 5, 2014–New York- based securities law firm, Sichenzia Ross Friedman Ference LLP, advised FreeSeas Inc. (NASDAQ: FREE), a transporter of dry-bulk cargoes through the ownership and operation of a fleet of five Handysize and one Handymax vessels, in a recently completed $25 million registered direct public offering of Series D Convertible Preferred Stock and Series C Warrants. The securities consisted of one share of the Company’s Series D Convertible Preferred Stock and 184 Series C Warrants, exercisable for five years at an initial price of $1.42 per share. Each share of Series D Preferred Stock has a stated value of $100 and is convertible into a number of shares of common stock equal to $100 divided by $1.09. The Sichenzia Ross Friedman Ference LLP team was led by partners Marc J. Ross and James M. Turner.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $20 Million Public Offering of Spherix Inc.

    spherix intellectual property

    NEW YORK, June 4, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as the sole placement agent in a $20 million public offering for Spherix, Inc. (NASDAQ: SPEX). The company offered a Series J preferred stock at a purchase price of $2.00 per share. Spherix Inc. is traded on the NASDAQ Capital Market under the trading symbol “SPEX”. The Sichenzia Ross Friedman Ference LLP team was led by partners Harvey Kesner, Richard A. Friedman and associates Tara Guarneri-Ferrara, and counsel Avital Even-Shoshan.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Drone Aviation Holding Corp. on Acquisition of Assets and $1.35 million PIPE Offering

    drone aviation

    NEW YORK, June, 4, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Drone Aviation Holding Corp. formerly known as Macrosolve (OTCQB: DRNE) in the acquisition of certain assets involved in the development of tethered drone based products. Simultaneously, Sichenzia Ross Friedman Ference LLP has represented Drone Aviation Holding Corp. on a $1.35 million private placement consisting of preferred stock and warrants at a purchase price of $.50 per unit. Drone Aviation Holding Corp. is a producer of drone applications. The Sichenzia Ross Friedman Ference LLP team was led by partner Gregory Sichenzia, Harvey Kesner and associate Tara Guarneri-Ferrara.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Zenovia Digital Exchange Corp. on $5 Million Private Placement Transaction

    zenovia

    June 4, 2014 – New York- based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to Zenovia Digital Exchange Corp., a company that provides a Software as a Service-based technology platform for advertisers to access viewable media from publishers worldwide, in its recently completed private placement of units consisting of secured notes and warrants. The company raised an aggregate of $5.0 Million. Aegis Capital Corp. acted as the placement agent in the offering. The Sichenzia Ross Friedman Ference LLP team was led by partners Tom Rose and Marcelle Balcombe.

    Media Contact

    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Vuzix Corporation on a $3 Million PIPE Offering

    vuzix

    NEW YORK, June 3, 2014 (GLOBE NEWSWIRE) — New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Vuzix Corporation (OTCQB: VUZI) on a $3 million private placement consisting of convertible 5% secured promissory notes, convertible at $2.25 per share. Vuzix Corporation is engaged in the design, manufacture, marketing and sale of wearable Video Eyewear products for use as an alternative private display solution in markets where portability and high resolution are key. The Sichenzia Ross Friedman Ference LLP team was led by partner Gregory Sichenzia and Peter DiChiara.

    CONTACT:

    Sichenzia Ross Friedman Ference LLP
    Gregory Sichenzia
    212-930-9700
    gsichenzia@srfkllp.com

    Gregory Sichenzia, Esq.

    Gregory Sichenzia, Esq.

    Gregory Sichenzia, a founding member, counsels public and private companies in all securities laws matters, from complex financing transactions and listings on various stock exchanges through everyday regulatory requirements. He has also been responsible for structuring innovative merger and acquisition transactions. Throughout his career he has represented many companies and investment banks in initial public offerings of securities, and has represented numerous public companies in private equity financing transactions (“PIPEs”) and the resulting resale regist
    Gregory Sichenzia, Esq.

    Latest posts by Gregory Sichenzia, Esq. (see all)

      Sichenzia Ross Friedman Ference LLP Advises Calpian Inc. on $8.3 Million Private Placement of Common Stock and Warrants

      calpian

      May 27, 2014 (GLOBE NEWSWIRE) – New York-based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Calpian Inc. (OTCQB: CLPI), a global processing and mobile payments technology company, on a private placement offering of units in the aggregate amount of $8.3 million. Each unit consisted of one share of common stock and a warrant to purchase one fifth of one share of common stock, priced at $1.00 per unit. The warrants are exercisable at $1.25 per share. National Securities acted as the lead placement agent. The Sichenzia Ross  Friedman Ference LLP team was led by partner Darrin M. Ocasio and associate Jay Yamamoto.

      Media Contact
      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Sorrento Therapeutics, Inc. on $25.0 million Public Offering of Common Stock

      sorrento

      NEW YORK, May 20, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Sorrento Therapeutics, Inc. (NASDAQ: SRNE), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, in a $25.0 million public offering. The offering consists of 4,765,000 shares of common stock priced at $5.25 per share. The Sichenzia Ross Friedman Ference LLP team was led by partners Jeff Fessler and Marcelle Balcombe.

      Media Contact
      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Secondary Public Offering of Cyclacel Pharmaceuticals, Inc.

      cyclacel

      NEW YORK, April 8, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as sole underwriter in a $10 million secondary public offering for Cyclacel Pharmaceuticals, Inc. (“CYCC.” NASDAQ). The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 2,857,143 shares of common stock at an offering price of $3.50 per share. The Sichenzia Ross Friedman Ference LLP team was led by partners Richard Friedman and Stephen Cohen.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Genius Brands International, Inc. on $6.0 million PIPE Offering

      genius brands

      NEW YORK, March 26, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Genius Brands International, Inc. (GNUS. OTCQB) on a $6.0 million private placement of Series A Convertible Preferred Stock with a conversion price of $2.00 per share. Genius Brands is multimedia content and brand management company. Chardan Capital Markets LLC acted. as sole placement agent for the offering. The Sichenzia Ross Friedman Ference LLP team was led by partners Harvey Kesner and associate Tara Guarneri-Ferrara.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $6.72 million Secondary Public Offering of Novabay Pharmaceuticals, Inc.

      novabay pharma

      NEW YORK, March 25, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as sole underwriter in a $6.72 million secondary public offering for Novabay Pharmaceuticals, Inc. (“NBY” NYSE MKT). The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 5,600,000 shares of common stock and 18 month warrants to purchase 1,400,000 shares of common stock at combined offering price of $1.20 . The Sichenzia Ross Friedman Ference LLP team was led by partners Richard Friedman and Stephen Cohen.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Private Placement of Relmada Therapeutics, Inc.

      relmada

      NEW YORK, May 12, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as sole Placement Agent in a $10 million Private Placement offering for Relmada Therapeutics, Inc., a privately held company. The offering was of Units consisting of Common Stock and Class A and B Warrants. The Sichenzia Ross Friedman Ference LLP team was led by partners Richard Friedman and Stephen Cohen.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Marathon Patent on $6.5 million PIPE Offering

      marathon

      NEW YORK, May 5, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Marathon Patent Group, Inc. (OTCBB: MARA) on a $6.5 million private placement of units consisting of Series A Preferred Stock and warrants at a unit price of $6.50 per unit. Marathon is an intellectual property services and monetization company. Laidlaw & Company (UK) Ltd. as sole placement agent for the offering. The Sichenzia Ross Friedman Ference LLP team was led by partners Harvey Kesner and Counsel Edward Schauder.

      Media Contact:
      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering

      av therapeutics

      NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) — New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented AV Therapeutics, Inc. (OTCQB:AVTH) on a $1.26 million private placement of units consisting of common stock and warrants at a unit price of $0.20. AV Therapeutics, Inc. is engaged in the business of developing cancer therapeutics and immunotherapeutic vaccines that can be used alone or in combination with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. The Sichenzia Ross Friedman Ference LLP team was led by partner Darrin M. Ocasio.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company, L.L.C on $ 2.5 million Private Placement of X2 Bio Systems, Inc..

      xz biosystems

      NEW YORK, April 18, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented J.P. Turner & Company as sole Placement Agent in a $2.5 million private placement of X2 Bio systems, Inc., a privately held Seattle based science and technology company which is developing the first complete solution for assessing sport brain injuries. The offering consisted of $2.5 million of Units consisting of 6% convertible promissory notes and common stock purchase warrants. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia and David Manno.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Conkwest, Inc. on $7.06 million Private Placement of Units consisting of Series C Convertible Preferred Stock and Warrants to Purchase Common Stock.

      conkwest

      NEW YORK, April 11, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Conkwest, Inc. in a $7.06 million private placement of the Preferred Stock and Warrants of Conkwest, Inc., a privately held company which is involved in the development of immunotherapeutic treatments for cancers and debilitating viral infections using targeted cancer killing cell-lines. continue reading >>

      Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. on $2.1 million Secondary Public Offering of Intellicheck Mobilisa, Inc.

      intellicheck mobilisa

      NEW YORK, April 9, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Aegis Capital Corp. as sole underwriter in a $2.1 million secondary public offering for Intellicheck Mobilisa (“IDN” NYSE MKT. The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 2,617,000 shares at an offering price of $.80 per share. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia and Marcelle Balcombe.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Spherix Incorporated on $4.4 million PIPE Offering

      spherix intellectual property

      NEW YORK, March 26, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Spherix Incorporated (SPEX. NASDAQ) on a $4.4 million private placement of units consisting of Common Stock and warrants at a unit price of $3.75. Spherix is an intellectual property company that owns patented and unpatented intellectual property. Laidlaw & Company (UK) Ltd. as sole placement agent for the offering. The Sichenzia Ross Friedman Ference LLP team was led by partners Harvey Kesner and associate Tara Guarneri-Ferrara.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Brean Capital LLC on $ 6.5 million Registered Direct Offering of ClearSign Combustion Corporation

      clearsign

      NEW YORK, March 5, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Brean Capital LLC. as sole Placement Agent in a $6.5 million registered direct offering for ClearSign Combustion Corporation (“CLIR” NASDAQ). The offering was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 812,500 shares at an offering price of $8.00 per share. The Sichenzia Ross Friedman Ference LLP team was led by partner Jay Kaplowitz and associate Stephen Cohen

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $43.5 Million Shelf Takedown

      tonix pharmaceuticals

      SRFF Named-Partner, Marc J. Ross, Leads Transaction Whose Proceeds Will fund Development of Medications for the Treatment of Fibromyalgia and Post-Traumatic Stress Disorder

      NEW YORK CITY – February 12, 2014 Sichenzia Ross Friedman Ference LLP (SRFF), a leading corporate securities law firm headquartered in New York City, announces it represented Tonix Pharmaceuticals Holding Corp. (TNXP) in the closing of its confidentially marketed public offering, resulting in aggregate gross proceeds of approximately $43.5 million. The shelf takedown, which closed January 29, 2014, was led by SRFF named partner Marc J. Ross.

      The SRFF team, which in addition to Ross as lead counsel included firm partner James M. Turner, advised Tonix in the underwritten public offering of 2,898,550 shares of the common stock at a price of $15.00 per share. Roth Capital Partners acted as the sole book-running manager for the offering and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NHLD), acted as co-manager. Tonix granted the underwriters a 45-day option to acquire an additional 434,782 shares to cover overallotments in connection with the offering.

      Tonix Pharmaceuticals develops prescription medications for disorders of the central nervous system, targeting conditions characterized by significant unmet medical needs, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. Tonix expects to use the net proceeds of the offering to support the continued development of TNX-102 SL for the treatment of fibromyalgia, to initiate clinical trials of TNX-102 SL for the treatment of post-traumatic stress disorder, and to initiate clinical trials of TNX-201 for tension-type headache.

      Avista Capital Partners

      Last modified: 2013-12-16T13:14:39Z

      Copyright 2013 . All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

      Media Contact:

      pr@srfkllp.com
      (212) 930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP